Important information and usage precautions in the clofazimine package insert

Clofazimine is an antibiotic drug used to treat leprosy and drug-resistant tuberculosis. It belongs to the naphthyridine class of drugs and works by inhibiting the growth and reproduction of bacteria. Clofazimine has a strong antibacterial effect against Mycobacterium tuberculosis and other bacteria and is often used in combination with other anti-tuberculosis drugs. The package insert for this drug contains important information when using it. Patients should pay special attention to the following matters when using it.
1. Drug indications
Clofazimine is mainly used to treat leprosy caused by Mycobacterium leprae and tuberculosis infections caused by drug-resistant Mycobacterium tuberculosis. Leprosy is a chronic infectious disease caused by bacteria such as Mycobacterium leprae, while tuberculosis is a respiratory disease caused by bacteria such as Mycobacterium tuberculosis. When treating leprosy and drug-resistant tuberculosis, clofazimine is often used in combination with other antibiotics to enhance efficacy and reduce the risk of drug resistance.
2. Drug action mechanism
Clofazimine inhibits bacterial growth by binding to bacterial DNA and interfering with its replication and repair processes. Its mechanism of action gives it good antibacterial activity against bacteria such as mycobacteria. In addition, clofazimine also has a certain anti-inflammatory effect, so it can reduce the inflammatory response and improve the patient's symptoms when treating diseases such as leprosy.
3. Dosage and method of use
The dose of clofazimine should be adjusted based on the patient's age, weight, condition, and comorbidities. Typically, the starting dose for adults is 100 mg to 300 mg daily, with the dose gradually adjusted according to the patient's tolerance. In the treatment of leprosy, clofazimine is usually used in combination with other anti-leprosy drugs for a longer treatment period, usually several months to a year. For the treatment of tuberculosis, clofazimine should also be used in combination with other anti-tuberculosis drugs for a treatment period of 6 to 12 months.

Clofazimine tablets should be taken by mouth, preferably with meals to reduce gastrointestinal discomfort. Patients should follow the doctor's instructions and regularly review blood indicators, liver and kidney functions, etc. to ensure the safety of medication.

4. Common side effects
Clofazimine may cause some side effects. Common side effects include:
Skin reactions: The most common side effect is a change in skin color. Clofazimine may cause discoloration of the skin, especially on the face and extremities, often appearing red or brown. This is a normal reaction to the drug and usually does not require stopping the medication, but if the pigment change affects the patient's appearance, you can communicate with your doctor.
Gastrointestinal discomfort: Patients may experience gastrointestinal symptoms such as nausea, vomiting, and diarrhea while taking clofazimine. It is best to take the medicine with food to reduce gastrointestinal discomfort.
Abnormal liver function: Long-term use of clofazimine may cause elevated liver enzymes or abnormal liver function, especially in patients with underlying liver disease. Patients should check their liver function regularly and seek medical attention promptly if symptoms such as jaundice, loss of appetite, and upper abdominal discomfort occur.
Anaphylaxis: Although rare, some patients may experience allergic reactions, with symptoms including rash, itching, and difficulty breathing. If an allergic reaction occurs, discontinue medication immediately and seek medical help.
5. Contraindications and Precautions
Pregnant and lactating women: The safety of clofazimine in pregnant women has not been established, and pregnant women should follow their doctor's advice when using it. Since clofazimine may be excreted into the baby's body through breast milk, nursing mothers should avoid breastfeeding when using it.
Hepatic and renal insufficiency: Clofazimine is metabolized by the liver and excreted by the kidneys, so patients with hepatic and renal insufficiency should use it with caution, adjust the dose if necessary, and check liver and kidney function regularly.
Precautions when using other drugs in combination: There may be drug interactions when clofazimine is used in combination with other drugs, especially when used in combination with other anti-tuberculosis drugs or immunosuppressants. Pay attention to drug interactions to avoid increasing side effects or reducing efficacy.
6. Use by special groups
Children: The safety and effectiveness of clofazimine have not been fully established for use in children; therefore, children should follow the guidance of a professional physician when using this drug.
Elderly patients: Elderly patients may have poor metabolism of drugs due to reduced physical function, so they need to be cautious when using clofazimine, and the dose may need to be adjusted according to the patient's specific conditions.
7. Drug Storage
Clofazimine should be stored in a cool, dry place away from direct sunlight and moisture. Medications should be kept out of the reach of children. Avoid storing medications in hot or humid environments to maintain their effectiveness.
Clofazimine is an effective antibiotic drug mainly used to treat leprosy and drug-resistant tuberculosis. Patients need to follow their doctor's advice when using this drug, pay attention to side effects and contraindications, and especially monitor liver and kidney function, skin reactions and gastrointestinal symptoms regularly. Although side effects of clofazimine are relatively common, generally speaking, with reasonable dose adjustment and monitoring, these adverse reactions can be effectively managed to ensure the safety and effectiveness of the treatment.
Reference: https://www.novartis.com/our-products/pipeline/clofazimine